Qifeng Wang

发表

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study

Lei Wu, Wenwu He, Yongtao Han, 2022, Frontiers in Immunology.

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.

Qi Li, P. Keegan, Jianxing He, 2022, Cancer cell.

“Sandwich Therapy”—Immunotherapy Plus Concurrent Chemoradiotherapy for Advanced Esophagogastric Junction Carcinoma: Report of Two Cases and Literature Review

Lei Wu, Juan Liu, Mian Mao, 2022, Frontiers in Oncology.

Translation and adaptation of the EORTC QLQ-LC 29 for use in Chinese patients with lung cancer

C. Pompili, W. Dai, Qiang Li, 2021, Journal of Patient-Reported Outcomes.

Prognostic value of nutritional and inflammatory indicators in females with esophageal squamous cell cancer: A propensity score matching study

Dongsheng Wang, Qiao He, Kaijiong Zhang, 2022, Frontiers in Genetics.

Nomogram-Based Survival Predictions and Treatment Recommendations for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Upfront Surgery

Lei Wu, Yongtao Han, Yan Tan, 2022, Cancers.

Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials

Lei Wu, Yongtao Han, Binyang Gao, 2022, Frontiers in Immunology.

Lymph Drainage and Cervical Fascia Anatomy-Oriented Differential Nodal CTV Delineation at the Supraclavicular Region for Esophageal Cancer and Nasopharyngeal Cancer.

Shichuan Zhang, Shilong Shao, Dan Wang, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma

Q. Xue, Jun Liang, Y. Mao, 2022, Frontiers in Oncology.

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Lei Wu, Yongtao Han, G. Wan, 2022, Radiation Oncology.

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study

Churong Li, J. Lang, P. Diao, 2018, Radiation Oncology.

The Clinical Application Value of the Prognostic Nutritional Index for the Overall Survival Prognosis of Patients with Esophageal Cancer: A Robust Real-World Observational Study in China

Ying Lin, Guishu Yang, Dongsheng Wang, 2022, Computational and Mathematical Methods in Medicine.

The prognostic value of positron emission tomography/computed tomography-based parameters in locally advanced esophageal squamous cell carcinoma treated with chemoradiation therapy

Wei Zhang, B. Cao, Wei Diao, 2022, Nuclear medicine communications.

Pretreatment Low Serum Sodium as a Prognostic Factor for Patients with Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy

Lei Wu, J. Lang, Tao Li, 2022, Journal of oncology.

The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study

W. Feng, Tao Zhang, W. Liao, 2022, Frontiers in Medicine.

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Lei Wu, G. Wan, Lin Peng, 2022, Radiation Oncology.

Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Lei Wu, G. Wan, Lin Peng, 2023, Radiation Oncology.

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma

Xinchen Sun, Jianyang Wang, Zongmei Zhou, 2023, JAMA network open.

Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume

Li Jiang, Kaijiong Zhang, Jie Tang, 2022, Frontiers in Oncology.

Prognostic significance and postoperative chemoradiotherapy guiding value of mean platelet volume for locally advanced esophageal squamous cell carcinoma patients

B. Cao, Wei Diao, Zhuzhong Cheng, 2023, Frontiers in Oncology.

Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016

X. Wang, Wei Jiang, Lei Wu, 2023, Journal of the National Cancer Center.

Preparation, Characterization, In Vitro Release and Degradation of Cathelicidin-BF-30-PLGA Microspheres

Hongli Li, Minglong Yuan, Mingwei Yuan, 2014, PloS one.

Machine learning‑based prediction of survival prognosis in esophageal squamous cell carcinoma

Peng Zhang, Dongsheng Wang, Kaijiong Zhang, 2023, Scientific reports.

Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer.

Zhiwei Zhang, Deyong Yang, Jianbo Wang, 2016, Oncology letters.

Long-term survival of esophageal squamous cell carcinoma after surgical treatment in a large-scale retrospective study from a single cancer center

Jialong Li, Wenwu He, Kun Liu, 2023, Holistic Integrative Oncology.

Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis

Wenwu He, X. Leng, Cheng-guo Wang, 2024, Annals of surgical oncology.

To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment

X. Leng, Qifeng Wang, Zongyao Huang, 2024, Frontiers in immunology.

Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study.

X. Leng, Yi Wang, Qifeng Wang, 2024, Annals of surgical oncology.

Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis.

X. Leng, Qifeng Wang, Kexun Li, 2024, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma

Wenwu He, X. Leng, Cheng-guo Wang, 2023, Frontiers in immunology.

Prognostic significance of positive lymph node regression grade to neoadjuvant chemoradiation for esophageal squamous cell carcinoma

X. Leng, Qifeng Wang, Chengmin Zhou, 2023, Journal of surgical oncology.

EUS–derived maximum tumor thickness and tumor shrinkage rate as independent prognostic factors in locally advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy

X. Leng, Yi Wang, Qifeng Wang, 2023, Endoscopic ultrasound.

A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma

Dongsheng Wang, Yao Deng, Kaijiong Zhang, 2023, Cancer medicine.